2021 -
now Head of Translational Research and Alliance Management @
2017 -
2021 Technology Development Manager @
2016 -
2017 Scientific Advisor and Writer @ (Scientific Writing/ R&D Consulting/ Translational & Early Pharmaceutical Develo
2015 -
2015 Visiting Scientist @
2005 -
2015 Senior Scientist of Translational and Clinical Research @
2002 -
2004 Scientist @ Atugen AG (now Silence Therapeutics)
1998 -
2002 Postdoctoral Fellow @
Ansgar Santel Education
Philipps-Universität Marburg 1990
-
1998
Ansgar Santel Skills
Preclinical Development
Translational Medicine
Cell Biology
In Vivo
Genomics
Clinical Research
Biotechnology
Regulatory Affairs
Life Sciences
Translational Research
Drug Discovery
Molecular Biology
Research and Development R&d
Lifesciences
Oncology
Drug Development
Clinical Development
In Vitro
Cancer
Biochemistry
RNAi
Pharmaceutical Industry
R&d
Biopharmaceuticals
Research and Development
Ansgar Santel Summary
Ansgar Santel, based in Berlin, DE, is currently a Chief Executive Officer at Pantherna Therapeutics GmbH. Ansgar Santel brings experience from previous roles at Pantherna Therapeutics GmbH, Ascenion GmbH, (Scientific Writing/ R&D Consulting/ Translational & Early Pharmaceutical Develo and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Ansgar Santel holds a 1990 - 1998 Philipps-Universität Marburg. With a robust skill set that includes Preclinical Development, Translational Medicine, Cell Biology, In Vivo, Genomics and more. Ansgar Santel has 3 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.